When 'bacteriostatic' evolves into 'long-lasting bacteriostatic', the sanitary pad industry is undergoing a quiet restructuring from metrics to supply chain. Released in August 2026, the T/CIAA 008-2026 group standard for the first time mandates simulated post-use efficacy, replacing the old 'pass at factory' logic with 'still effective after use'. The ripple effects on raw materials, additives, and testing are becoming visible.
Three Key Changes in the Revised Standard
The core of this revision is an expanded scope. The original standard only covered 'bacteriostatic sanitary pads (panty liners)', while the new one includes 'period pants' and adds a definition for 'long-lasting antimicrobial (bacteriostatic)'—requiring the addition of bovine serum albumin on the skin-contact layer and placement at (36±1)°C for at least 8 hours to simulate post-use efficacy. This clause directly addresses consumer demand for prolonged protection and moves testing from the lab to realistic usage scenarios.
Another major adjustment is full alignment with GB 15979-2024 'Hygienic requirements for disposable sanitary products'. The new standard revises requirements for antibacterial performance, bacteriostatic performance, stability, and toxicology, along with updated test methods. Products designed under the old national standard may need revalidation. For the supply chain, this is not just a text replacement but involves equipment upgrades and increased costs.
Notably, the standard is coordinated by the Zhongguancun Huizhi Antimicrobial New Material Industry Technology Innovation Alliance, with drafting units including Henan Shulai, Guangdong Institute of Microbiology, SGS, and Jinda Nano Technology, covering production, research, testing, and materials. This cross-sector drafting team suggests the standard is a collaborative effort, likely to gain higher industry acceptance than typical group standards.
Industry Impact: From Compliance to Differentiation
For manufacturers, the most direct impact is rising testing costs. Long-lasting efficacy tests require additional bovine serum albumin and constant-temperature equipment, extending test cycles and requiring post-use sampling, which is more complex than traditional tests. Small brands unable to afford new costs may exit the antibacterial segment, potentially increasing industry concentration.
For upstream suppliers of nonwovens, absorbent cores, and antibacterial additives, the new standard creates product opportunities. The long-lasting requirement means antimicrobial agents need better resistance to sweat and moisture, potentially driving optimization of traditional silver ion or quaternary ammonium additives. Additionally, the inclusion of period pants will boost demand for elastic materials and breathable films.
For testing laboratories, the standard brings business expansion but also raises the bar by requiring bovine serum albumin handling and controlled humidity. Buyers should verify that supplier test reports are issued under the new standard to avoid compliance risks.